Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Heart failure app keeps patients safe amidst pandemic
Medly cuts re-hospitalizations for heart failure by 50%
How genomic research can impact families in real-time
Direct translation from research to clinic
Predicting heart risk before treatment for breast cancer
Unique new model to empower patients, assist physicians
High-quality stem cells enable researchers to better study almost any disease
Novel technique is blueprint to creating precision disease models
Ted Rogers Centre for Heart Research celebrates fifth anniversary
The promise of a record gift is coming to fruition
Heart failure app puts control back in the hands of patients
Medly is the future of heart failure care
Behind the Breakthrough with Dr. Heather Ross
Our scientific lead talks heart failure, AI, and a near-death experience.
Why we must screen early in life for hypertrophic cardiomyopathy
New study aims to change screening guidelines
ECHO program supports efforts to prevent ischemia-reperfusion injury in the heart
A novel peptide may solve this phenomenon
Our 2019 Innovation Fund awards: 3D models of heart failure… stiffened hearts in diabetes…. saving infant lives
Three bold projects target special challenges in HF